시장보고서
상품코드
1596908

임상 영양 시장 규모, 점유율, 성장 분석 : 부문별 및 지역별 산업 예측(2024-2031년)

Clinical Nutrition Market Size, Share, Growth Analysis, By Route of Administration (Oral, Parenteral) By Application (Cancer, Neurological Diseases), By Distribution Channel, By End User, By Region - Industry Forecast 2024-2031

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 165 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

임상 영양(Clinical Nutrition) 시장 규모는 2022년 356억 달러로 평가되었고, 2023년 387억 달러에서 2031년 711억 달러로 성장하며 예측기간 중(2024-2031년) CAGR은 7.9%로 추이하며 성장할 전망입니다.

임상 영양 시장은 맞춤형 영양 지원의 필요성을 강조하는 당뇨병 및 염증성 장 질환과 같은 생활 습관 관련 질병의 유병률 증가에 힘입어 크게 성장할 것으로 전망됩니다. 임상 영양학은 환자의 건강 증진을 목표로 필수 비타민, 미네랄, 영양소를 통해 신진대사 시스템을 최적화하는 데 중점을 둡니다. 심장 재활, 신장 투석, 소아 영양, 암 지원, 외상 회복, 웰니스 이니셔티브 등 다양한 분야에 걸쳐 적용되어 의료 분야에서 다재다능함을 입증하고 있습니다. 인구 고령화와 의료 연구 및 개발에 대한 정부의 막대한 투자는 시장 확대를 더욱 촉진하고 있습니다. 또한 아시아 태평양 및 라틴 아메리카와 같은 신흥 지역에서 임상 영양에 대한 수요가 증가하고 홈 헬스케어 솔루션에 대한 수요가 증가함에 따라 글로벌 임상 영양 시장은 예측 기간 동안 매력적인 투자 기회로 자리 매김하고 있습니다. 의료가 계속 발전함에 따라 임상 영양을 치료 계획과 예방 치료 전략에 통합하는 것은 건강 결과를 개선하고 다양한 인구의 영양 요구를 해결하는 데 중요한 역할을 할 것입니다.

목차

소개

  • 조사 목적
  • 조사 범위
  • 정의

조사 방법

  • 정보 조달
  • 2차 및 1차 데이터 방법
  • 시장 규모 예측
  • 시장 전제 조건 및 제한 사항

주요 요약

  • 세계 시장 전망
  • 공급 및 수요 동향 분석
  • 부문별 기회 분석

시장 역학 및 전망

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 성장 촉진요인 및 기회
    • 억제요인 및 과제
  • Porter's Five Forces 분석 및 영향
    • 경쟁 기업간 경쟁 관계
    • 대체품의 위협
    • 구매자의 협상력
    • 신규 참가업체의 위협
    • 공급기업의 협상력

주요 시장 인사이트

  • 중요 성공 요인
  • 경쟁도
  • 주요 투자 기회
  • 시장 생태계
  • 규제 상황
  • 특허 분석
  • 밸류체인 분석
  • PESTEL 분석
  • 시장 매력 지수
  • 원재료 분석
  • 가격 분석

임상 영양 시장 규모 : 투여 경로별

  • 시장 개요
  • 경구
  • 비경구
  • 경장

임상 영양 시장 규모 : 용도별

  • 시장 개요
  • 신경질환
  • 위장 장애
  • 대사 장애
  • 기타

임상 영양 시장 규모 : 유통 채널별

  • 시장 개요
  • 온라인
  • 오프라인
    • 소매점
    • 기업용 판매 채널
    • 기타

임상 영양 시장 규모 : 최종 사용자별

  • 시장 개요
  • 소아
  • 성인
  • 고령자

임상 영양 시장 규모 : 영양 성분별

  • 시장 개요
  • 단백질 기반 영양
  • 비타민과 미네랄이 풍부한 영양
  • 탄수화물 기반 영양
  • 지방 기반 영양

임상 영양 시장 규모 : 지역별

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 스페인
    • 프랑스
    • 이탈리아
    • 기타 유럽
  • 아시아 태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아 태평양
  • 남미
    • 브라질
    • 기타 남미
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 정보

  • 상위 5개사 비교
  • 주요 기업 시장 포지셔닝(2023년)
  • 주요 시장 기업이 채택한 전략
  • 시장의 최근 동향
  • 기업 시장 점유율 분석(2023년)
  • 주요 기업 프로파일
    • 기업 개요
    • 제품 포트폴리오 분석
    • 부문별 점유율 분석
    • 수익 전년대비 비교(2021-2023년)

주요 기업 프로파일

  • Abbott Laboratories(미국)
  • Nestle Health Science(스위스)
  • Danone Nutricia(프랑스)
  • Fresenius Kabi(독일)
  • Baxter International(미국)
  • B. Braun Melsungen AG(독일)
  • Mead Johnson Nutrition(Reckitt)(미국)
  • GlaxoSmithKline(GSK)(영국)
  • Pfizer(미국)
  • Ajinomoto Co., Inc.(일본)
  • Koninklijke DSM NV(네덜란드)
  • Lonza Group(스위스)
  • Cambrooke Therapeutics(미국)
  • Sichuan Kelun Pharmaceutical Co. Ltd.(중국)
  • Otsuka Pharmaceutical(일본)
  • Hormel Health Labs(미국)
  • Perrigo Company(Ireland)
  • Hero Group(스위스)
  • Victus(미국)
  • Entrocare Nutritional Solutions(영국)

결론 및 권장사항

LYJ

Global Clinical Nutrition Market size was valued at USD 35.6 billion in 2022 and is poised to grow from USD 38.7 billion in 2023 to USD 71.1 billion by 2031, growing at a CAGR of 7.9% during the forecast period (2024-2031).

The clinical nutrition market is poised for significant growth, driven by the increasing prevalence of lifestyle-related diseases such as diabetes and inflammatory bowel disease, which highlight the need for tailored nutritional support. Clinical nutrition focuses on optimizing the metabolic system through essential vitamins, minerals, and nutrients aimed at enhancing patient health. Its applications span various sectors, including cardiac rehabilitation, renal dialysis, pediatric nutrition, cancer support, trauma recovery, and wellness initiatives, underpinning its versatility in healthcare. The aging population and substantial government investments in healthcare research and development further bolster market expansion. Additionally, the rising demand for clinical nutrition in emerging regions such as Asia-Pacific and Latin America, coupled with a growing trend towards home healthcare solutions, positions the global clinical nutrition market as an attractive investment opportunity during the forecast period. As healthcare continues to evolve, the integration of clinical nutrition into treatment plans and preventive care strategies will play a crucial role in improving health outcomes and addressing the nutritional needs of diverse populations.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Clinical Nutrition market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Clinical Nutrition Market Segmental Analysis

Global Clinical Nutrition Market is segmented by Route of Administration, application, Distribution Channel, end user, Nutritional Content and region. Based on Route of Administration, the market is segmented into Oral, Parenteral, and Enteral. Based on Application, the market is segmented into Cancer, Neurological Diseases, Gastrointestinal Disorder, Metabolic Disorder, and Others. Based on Distribution Channel, the market is segmented into Online and Offline. Based on end user, the market is segmented into Paediatric, Adults, and Geriatric. Based on By Nutritional Content, the market is segmented into Protein-Based Nutrition, Vitamin and Mineral-Rich Nutrition, Carbohydrate-Based Nutrition, and Fat-Based Nutrition. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Clinical Nutrition Market

The global clinical nutrition market is experiencing significant growth due to the increasing prevalence of lifestyle-related diseases and the rising elderly population. As individuals age, their activity levels diminish, metabolic rates decrease, and energy needs decline, leading to a deterioration in their ability to absorb and utilize essential nutrients. This decline amplifies their nutritional requirements, creating a heightened demand for clinical nutrition solutions that enhance energy absorption and utilization. Consequently, the growing emphasis on meeting the specific nutritional needs of older adults is poised to drive market expansion throughout the forecast period, reflecting a broader trend towards proactive health management.

Restraints in the Global Clinical Nutrition Market

The Global Clinical Nutrition market faces significant challenges, primarily due to a lack of awareness and the high costs associated with clinical nutrition products. Despite a rising demand for therapeutic nutritional solutions, both healthcare professionals and the general public remain largely uninformed about the benefits of clinical nutrition in both developed and developing nations. This limited understanding has contributed to widespread misinformation regarding vitamins and dietary practices, leading to nutritional deficiencies and related health issues. Consequently, the inadequate knowledge and appreciation of clinical nutrition serve as substantial barriers to market growth, hindering its expansion throughout the forecast period.

Market Trends of the Global Clinical Nutrition Market

The Global Clinical Nutrition market is witnessing significant growth fueled by enhanced healthcare infrastructure and a rising necessity for improved healthcare solutions, particularly in emerging regions like Asia-Pacific and LAMEA. This trend is further accelerated by the alarming rise in lifestyle-related chronic diseases that contribute to malnutrition and dietary complications. As healthcare demands evolve, there is an increased emphasis on research and development of specialized medical devices aimed at addressing diverse health issues, including respiratory, renal, and oncological conditions. Consequently, these factors are creating lucrative opportunities for expansion and innovation within the clinical nutrition sector.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Regulatory Landscape
  • Patent Analysis
  • Value Chain Analysis
  • PESTEL Analysis
  • Market Attractiveness Index
  • Raw Material Analysis
  • Pricing Analysis

Global Clinical Nutrition Market Size by Route of Administration & CAGR (2024-2031)

  • Market Overview
  • Oral
  • Parenteral
  • Enteral

Global Clinical Nutrition Market Size by Application & CAGR (2024-2031)

  • Market Overview
  • Cancer
  • Neurological Diseases
  • Gastrointestinal Disorder
  • Metabolic Disorder
  • Others

Global Clinical Nutrition Market Size by Distribution Channel & CAGR (2024-2031)

  • Market Overview
  • Online
  • Offline
    • Retail Stores
    • Institutional Sales Channel
    • Others

Global Clinical Nutrition Market Size by End User & CAGR (2024-2031)

  • Market Overview
  • Pediatrics
  • Adults
  • Geriatric

Global Clinical Nutrition Market Size by Nutritional Content & CAGR (2024-2031)

  • Market Overview
  • Protein-Based Nutrition
  • Vitamin and Mineral-Rich Nutrition
  • Carbohydrate-Based Nutrition
  • Fat-Based Nutrition

Global Clinical Nutrition Market Size & CAGR (2024-2031)

  • North America, (By Route of Administration, By Application, By Distribution Channel, By End User, By Nutritional Content)
    • US
    • Canada
  • Europe, (By Route of Administration, By Application, By Distribution Channel, By End User, By Nutritional Content)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific, (By Route of Administration, By Application, By Distribution Channel, By End User, By Nutritional Content)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America, (By Route of Administration, By Application, By Distribution Channel, By End User, By Nutritional Content)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa, (By Route of Administration, By Application, By Distribution Channel, By End User, By Nutritional Content)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Abbott Laboratories (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nestle Health Science (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danone Nutricia (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fresenius Kabi (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter International (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mead Johnson Nutrition (Reckitt) (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GlaxoSmithKline (GSK) (U.K.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ajinomoto Co., Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke DSM N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lonza Group (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cambrooke Therapeutics (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sichuan Kelun Pharmaceutical Co. Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Otsuka Pharmaceutical (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hormel Health Labs (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Perrigo Company (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hero Group (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Victus (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Entrocare Nutritional Solutions (U.K.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제